Table 1.
Demographic data and tumor-stage
| Patients demographics and clinical characteristics | CROSS n = 53 |
EOX n = 51 |
p value |
|---|---|---|---|
| Age, year a | 60.2 ± 9.2 | 60.1 ± 12.3 | 0.975 |
| Male gender | 48 (90.6) | 45 (88.2) | 0.703 |
| cT stageb | 0.023 | ||
| T1 | 0 (0.0) | 3 (6.8) | |
| T2 | 5 (11.9) | 8 (18.2) | |
| T3 | 37 (88.1) | 29 (65.9) | |
| T4 | 0 (0.0) | 4 (9.1) | |
| cN-stage c | 0.884 | ||
| N0 | 12 (30.8) | 12 (29.3) | |
| N+ | 27 (69.2) | 29 (70.7) |
Data are numbers of patients with percentages in parentheses
aData are mean ± standard deviation
bClinical tumor stage (cT) classified according to the 8th edition of the International Union Against Cancer (UICC) tumor-node-metastasis (TNM) classification [16]
cClinical lymph node (cN) stage classified according to the 8th edition of the UICC TNM classification [16]